MiMedx Group, Inc. Deferred Income Tax Expense (Benefit)
MiMedx Group, Inc. (MDXG) reported Deferred Income Tax Expense (Benefit) of $8.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-25
- MiMedx Group, Inc. deferred income tax expense (benefit) for fiscal 2025 was $8.71M, a 30.16% decline from fiscal 2024.
- MiMedx Group, Inc. deferred income tax expense (benefit) for fiscal 2024 was $12.47M.
- MiMedx Group, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$40.78M.
- MiMedx Group, Inc. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $8.71M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $12.47M 10-K · filed 2026-02-25 | |
| 2023-12-31 | -$40.78M 10-K · filed 2026-02-25 | |
| 2022-12-31 | $0.00 10-K · filed 2025-02-26 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |
| 2018-12-31 | $25.54M 10-K · filed 2021-03-08 | |
| 2017-12-31 | -$26.67M 10-K · filed 2020-07-06 | |
| 2016-12-31 | -$5.38M 10-K · filed 2020-03-17 | $10.00K 10-K · filed 2017-03-01 |
| 2015-12-31 | -$14.84M 10-K · filed 2017-03-01 | |
| 2014-12-31 | $0.00 10-K · filed 2017-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |